Radiation after surgery for early lung cancer you can’t remove
Part of Cancer, Lungs & breathing clinical trials.
This trial studies whether a focused form of radiation called SBRT can safely treat remaining lung cancer nodules after surgery. It may help people whose leftover tumor spots can’t be removed by more surgery, aiming to control the cancer while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 75
- You can manage daily activities (ECOG score 0–2)
- CT scan shows at least two lung nodules, including ground-glass or solid/part-solid ones
- At least one nodule has been confirmed as lung cancer that has not spread far (T1N0M0 to T1N1M0)
- You still have a leftover lung nodule that doctors agree looks like the main cancer, and you either can’t have surgery or choose not to have it
- You can understand the study, sign consent, and swallow tablets
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests how a single, high-dose radiation treatment (called SBRT) affects quality of life and outcomes for people with certain lung tumors. It's for adults with early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer, as long as the tumor is small and in the outer part of the lung.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
Hear when a new The Efficacy and Safety of SBRT in MPLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.